Gerald Proehl

Gerald Proehl has served as a director since April 2014 and Chairman since June 2021. Currently, Mr. Proehl is a Founder, President, CEO, and Director of Dermata Therapeutics, Inc, a private biotechnology company. From January 2002 to January 2014, Mr. Proehl was the President, Chief Executive Officer, and Director of Santarus, Inc. (“Santarus”), a company that he helped to found in 1999. From March 2000 through December 2001, Mr. Proehl was President and Chief Operating Officer of Santarus, and from April 1999 to March 2000, Mr. Proehl was Vice President, Marketing and Business Development of Santarus. Mr. Proehl helped lead the sale of Santarus to Salix Pharmaceuticals for $2.6 billion in January 2014. Prior to joining Santarus, Mr. Proehl was with HMR for 14 years where he served in various capacities, including Vice President of Global Marketing. During his career at HMR, he worked across numerous therapeutic areas, including CNS, cardiovascular, and gastrointestinal. Mr. Proehl holds a B.S. in education from the State University of New York at Cortland, an M.A. in exercise physiology from Wake Forest University and an M.B.A. from Rockhurst University.